A Case Report of Oral Bisphosphonate Treatment for... (2023 study) Skip to main content
Case Study The American journal of case reports 2023

A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture.

Fernandes TL, Viezzer Fernandes B, Jitumori C, Franco GCN, The American journal of case reports, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Doctors describe the case of a woman who developed a broken jaw and an unusual thigh bone fracture after taking a bisphosphonate drug for osteoporosis.

What They Found

This case report describes a 63-year-old woman treated with 70 mg of alendronate weekly for 2 years who developed medication-related osteonecrosis of the jaw (stage 3) leading to a pathologic mandibular fracture, alongside an atypical femoral fracture with osteomyelitis. Surgeons treated the jaw fracture with internal fixation, debridement, and sequestrectomy, and a second surgery to remove two mandibular implants was needed to control the infection. After stopping alendronate and completing 30 sessions of hyperbaric oxygen therapy, the jaw fracture was fully healed at the 3-year follow-up with no signs of infection or exposed bone. The authors note these adverse effects occurred with short-term bisphosphonate therapy, not just long-term use.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a single case report, so the findings cannot be generalized to all patients taking bisphosphonates and cannot establish that hyperbaric oxygen therapy alone caused the healing.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Study
Category Infection
Source Pubmed
PubMed ID 37867315
Year Published 2023
Journal The American journal of case reports
MeSH Terms Female; Humans; Middle Aged; Diphosphonates; Alendronate; Osteoporosis, Postmenopausal; Bone Density Conservation Agents; Mandibular Fractures; Osteoporosis; Fractures, Spontaneous; Femoral Fractures; Osteomyelitis

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology